Recon Strategy
Contact

Insights

Fifteen+ years of
healthcare thinking.

Several hundred perspectives on the questions facing payers, providers, biopharma, medtech, and digital health — plus our running read on the clinical literature. Start with our sharpest work, or filter to your world.

ESSENTIAL READING

  • Biopharma, Payers, Institutional

Outcomes Based Arrangements in Biopharma

Today’s advanced therapies target devastating diseases with high unmet need. Given the urgent medical need (and pressure from patient advocates), regulators increasingly must make decisions based on early, incomplete data when it comes to durability, real-world effectiveness, and cost-effectiveness – all while bearing costs that can exceed $1 million per patient.
  • Biopharma

A few thoughts about navigating biopharma macro scenarios

Planning biopharma strategies against a robust set of macro-scenarios will be crucial to mid- and long-term success. While historically these scenarios have revolved around targeted issues, the current challengescall for a more expansive - and likely more difficult - set of questions to be asked.
  • Biopharma, Payers, Providers, Medtech, Digital

Why the Best AI Won’t Win in Healthcare

As advanced AI becomes widely accessible, healthcare companies can no longer rely on superior technology alone for lasting advantage. Instead, they need a coherent AI strategy built around five interconnected choices. Harvard Business Review article.
Sector
All
NEJM opinion

Ambidextrous strategy: PART 2 – Scenario Implications

  • Payers , 
  • Providers
In our last post we introduced two potential scenarios. "Provider bas…

Read more

Ambidextrous strategy: PART 1 – Payer and provider strategy for two very different worlds

  • Payers , 
  • Providers
It seems like every day there’s some news outlining strategic actions …

Read more

Could a delay in the employer mandate be a boost to government run exchanges?

  • Payers
In 2011 we commented that while the health reform law, the ACA, had se…

Read more

When do you know ACOs are here to stay?

  • Payers , 
  • Providers
Answer:  When they form an industry association! Back in February, a …

Read more

Cleveland Clinic’s bold land grab in care improvement: the Community Health Systems deal

  • Providers
Summary The deal locks in an option for Cleveland Clinic to grow its …

Read more

Risk-taking providers in private exchanges: Medica’s “My Plan” private exchange

  • Payers , 
  • Providers
At a TEDMED conference a couple years ago, I had to write some sample …

Read more

Getting the troubled Highmark-West Penn relationship back on track: an outside-in speculation

  • Payers , 
  • Providers
Summary Highmark and the West Penn Allegheny Health System (WPAHS) ar…

Read more

Romance of convenience: perspectives on the IASIS-Aurora joint venture

  • Payers , 
  • Providers
Summary Two major hospital systems have agreed to a joint venture to …

Read more

Deploying analytics in a healthcare world flooded with data

  • Digital , 
We live in a society with too much data. In the field of market resear…

Read more

SELECTED ENGAGEMENTS

Insight, put to work

Our published thinking is one half of the picture. These are representative client engagements, anonymized — each tagged by sector, so you can trace the path from perspective to practice.

  • Institutional

Strategy for Statewide Health Information Exchange

A non-profit health information exchange was facing financial struggles and needed a new strategy that would keep it financially sustainable

HIE, Health IT,

  • Medtech, Early Stage

Growth strategy for point-of-care testing

Post pandemic an innovative diagnostics platform company wanted to dramatically increase its market by targeting retail clinics for its point-of-care diagnostics platform

Growth, product market fit, value proposition

  • Institutional

University Trials

Large university wanting to dramatically increase its clinical research footprint

Keep up with Recon Strategy Insights
Get an email each time we publish a new article